Sun Pharmaceutical Industries Limited

NSE:SUNPHARMA.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

💊 Drugstores & Retail Pharmacies

Location

India

Market Cap

USD 47.37 B

Share Price

USD 19.74

Avg Daily Volume

2,720,780

Change (1 day)

1.33%

Change (1 year)

8.72%

Change (YTD)

-10.41%

Sun Pharmaceutical Industries Limited Market Capitalization on June 27, 2025: USD 47.37 B

Sun Pharmaceutical Industries Limited Market Capitalization is USD 47.37 B on June 27, 2025, a 8.47% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Sun Pharmaceutical Industries Limited 52-week low Market Capitalization is USD 55.96 B on June 27, 2025, which is 18.14% above the current Market Capitalization.
Sun Pharmaceutical Industries Limited 52-week low Market Capitalization is USD 43.08 B on June 27, 2025, which is -9.04% below the current Market Capitalization.
Sun Pharmaceutical Industries Limited average Market Capitalization for the last 52 weeks is USD 49.58 B.

Daily

From:

To:

Zoom:

Key data

Date	Market Capitalization	Share Price	Share Price	Price to Earnings Ratio (P/E)

NSE: SUNPHARMA.NS

Sun Pharmaceutical Industries Limited

CEO	Mr. Abhay Gandhi
IPO Date	Jan. 1, 1996
Location	India
Headquarters	Sun House
Employees	43,000
Sector	🏥 Health Care
Industries Pharmaceuticals 💊 Drugstores & Retail Pharmacies

Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.